Levilactobacillus Brevis - Pertuzumab, Trastuzumab, Hyaluronidase-Zzxf Interaction Details

Interaction Details

There were no interactions found between Pertuzumab, Trastuzumab, Hyaluronidase-Zzxf and Levilactobacillus Brevis. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.

Still looking for more information about combining Pertuzumab, Trastuzumab, Hyaluronidase-Zzxf and Levilactobacillus Brevis? Ask Dr. Brian Staiger about it by contacting him directly.

Pertuzumab, Trastuzumab, Hyaluronidase-Zzxf Overview

The combination of pertuzumab, trastuzumab, and hyaluronidase-zzxf is used in combination with chemotherapy to treat certain types of early breast cancer that has spread to nearby tissues. It is also used to treat a certain type of early breast cancer to decrease the chance that a certain type of breast cancer will return. The combination of pertuzumab, trastuzumab, and hyaluronidase-zzxf is also used with docetaxel (Taxotere) to treat certain types of breast cancer that has spread to other parts of the body. Pertuzumab and trastuzumab are in a class of medications called monoclonal antibodies. They work by stopping the growth of cancer cells. Hyaluronidase is an endoglycosidase. It helps to keep pertuzumab and trastuzumab in the body longer so that these medications will have a greater effect.

See More Information Regarding Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection

Levilactobacillus Brevis - More Interactions

Levilactobacillus Brevis interacts with 179 drugs

Interaction Rating Key

These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.

Major	The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur.
Moderate	Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur.
Minor	Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction.
Unknown	No interactions have been reported or no interaction data is currently available.